Presentation is loading. Please wait.

Presentation is loading. Please wait.

The framework of analysis.

Published byΠύρρος Ασπάσιος Modified over 5 years ago

Similar presentations

Presentation on theme: "The framework of analysis."— Presentation transcript:

1 The framework of analysis.
The framework of analysis. Cost for the healthcare provider (National Health Service (NHS)): the cost data on scheduled healthcare visits to their usual physician and specialist, unscheduled healthcare asthma-related inpatient admissions, emergency visits and emergency contacts with a physician. Utility score: the gains in health utility (years in full health saved) measured using the Euroqol-5D score, where its values lie on a scale on which full health has a value between 1 (full health) and 0 (dead).8 For the purpose of this testing, the economic data were sourced from Vervloet et al.6 All cost data were actualised from 2005 to Euroqol 5D, Euroqol 5 dimensions. Michela Tinelli et al. BMJ Open Resp Res 2018;5:e000322 ©2018 by British Thoracic Society

Download ppt "The framework of analysis."

Similar presentations

Vitamin D3 increased ASL antimicrobial activity.

Vitamin D3 increased ASL antimicrobial activity.
Visual analogue scale (VAS) for pain on different procedures.

Visual analogue scale (VAS) for pain on different procedures.
The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)

The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)
Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.

Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.
(A) Changes in plaque and gingival index (Silness and Löe)21 for patients 1–8 over a 7-day period using oral hygiene intervention either with a toothbrush.

(A) Changes in plaque and gingival index (Silness and Löe)21 for patients 1–8 over a 7-day period using oral hygiene intervention either with a toothbrush.
Image of the form used by ambulance officers to triage patients with an exacerbation of chronic obstructive pulmonary disease (COPD).  GP, general practitioner;

Image of the form used by ambulance officers to triage patients with an exacerbation of chronic obstructive pulmonary disease (COPD).  GP, general practitioner;
Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.

Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.
Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3. Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3.

Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3. Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3.
The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.

The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.
For most patients with asthma airway response becomes flatter after 1000 µg of inhaled corticosteroid, but systemic activity (measured by serum cortisol.

For most patients with asthma airway response becomes flatter after 1000 µg of inhaled corticosteroid, but systemic activity (measured by serum cortisol.
Variable life adjusted display (VLAD chart) showing observed versus expected mortability with cumulative lives lost below the x-axis and cumulative lives.

Variable life adjusted display (VLAD chart) showing observed versus expected mortability with cumulative lives lost below the x-axis and cumulative lives.
Examination of the prevalence of asthma exacerbations and loss of asthma control throughout pregnancy in women with asthma. Examination of the prevalence.

Examination of the prevalence of asthma exacerbations and loss of asthma control throughout pregnancy in women with asthma. Examination of the prevalence.
Association of sputum colour score with (A) total cell counts; (B) neutrophil proportion; (C) neutrophil number and (D) CXCL-8 concentration. Association.

Association of sputum colour score with (A) total cell counts; (B) neutrophil proportion; (C) neutrophil number and (D) CXCL-8 concentration. Association.
Serum levels of angiopoietin-like protein 4 according to (A) cardiac dysfunction (ie, abnormal N-terminal pro-B-type natriuretic peptide level) and (B)

Serum levels of angiopoietin-like protein 4 according to (A) cardiac dysfunction (ie, abnormal N-terminal pro-B-type natriuretic peptide level) and (B)
Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study.

Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study.
(A) Refined profile principal component analysis loading weights plot was used to derive insight into possible association of biomarkers. (A) Refined profile.

(A) Refined profile principal component analysis loading weights plot was used to derive insight into possible association of biomarkers. (A) Refined profile.
Percentage of patients per stage of oesophageal cancers in the two trials, overall difference P

Percentage of patients per stage of oesophageal cancers in the two trials, overall difference P
Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.

Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.
Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.

Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.
A temperature inversion causing cold air drainage to accumulate as fog in the low-lying areas of the Tamar Valley and Midlands (Source: National Aeronautics.

A temperature inversion causing cold air drainage to accumulate as fog in the low-lying areas of the Tamar Valley and Midlands (Source: National Aeronautics.

Similar presentations

Ads by Google